IME says AI agents are live; EBITDA up 4x and raises growth targets
ImExHS says AI agents are now live in hospitals, citing improved EBITDA and stable recurring revenue. It targets 8—16% revenue growth and 48—66% EBITDA growth, with Colombia collections a key risk.
Story updates
02:12:58 AM UTC
SquawkNews
AI agents are now live in hospitals, driving improved EBITDA and stable recurring revenue. Radiology outperformed, while software growth was modest due to currency and investment. Guidance targets 8—16% revenue growth and 48—66% EBITDA growth, with collections in Colombia a key risk.Based on ImExHS…
AI agents are now live in hospitals, driving improved EBITDA and revenue growth.
Radiology outperformed, while software growth was modest but supported by new contracts and a growing partner network.
Guidance anticipates continued revenue and EBITDA gains, with a focus on collections and repeatable…